Lijuan Chen Selected Research

Dexamethasone (Maxidex)

10/2023	Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma.
1/2023	Daratumumab, Bortezomib, and Dexamethasone versus Bortezomib and Dexamethasone in Chinese Patients With Relapsed or Refractory Multiple Myeloma: Updated Analysis of LEPUS.
1/2022	Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study.
1/2021	Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study.
11/2020	Acquired heparin-like anticoagulation process in a patient with multiple myeloma: a case report and literature review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lijuan Chen Research Topics

Disease

152	Neoplasms (Cancer) 04/2024 - 01/2008
27	Multiple Myeloma 01/2024 - 01/2010
22	Inflammation (Inflammations) 04/2024 - 09/2009
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 05/2010
16	Neoplasm Metastasis (Metastasis) 01/2020 - 10/2010
14	Infections 04/2024 - 05/2011
13	Body Weight (Weight, Body) 12/2021 - 11/2010
12	Myocardial Infarction 01/2023 - 05/2009
12	Arthritis (Polyarthritis) 01/2021 - 11/2010
11	Edema (Dropsy) 01/2021 - 04/2011
10	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 04/2010
10	Carcinoma (Carcinomatosis) 01/2023 - 01/2009
9	Breast Neoplasms (Breast Cancer) 11/2023 - 08/2008
8	Leukemia 03/2023 - 01/2008
7	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2023 - 01/2011
7	Hypoxia (Hypoxemia) 01/2022 - 01/2009
7	Obesity 07/2015 - 06/2011
6	Lung Neoplasms (Lung Cancer) 01/2023 - 06/2014
6	Fibrosis (Cirrhosis) 08/2022 - 01/2006
6	Non-alcoholic Fatty Liver Disease 01/2018 - 06/2011
6	Ovarian Neoplasms (Ovarian Cancer) 08/2016 - 01/2008
5	Adenocarcinoma of Lung 04/2024 - 05/2020
5	Heart Failure 02/2023 - 10/2019
5	Type 2 Diabetes Mellitus (MODY) 01/2023 - 06/2012
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 02/2016
4	Idiopathic Pulmonary Fibrosis 02/2024 - 01/2011
4	Colitis 12/2023 - 01/2021
4	Thrombosis (Thrombus) 10/2023 - 01/2018
4	Disease Progression 01/2023 - 10/2008
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 05/2010
4	Hemorrhage 01/2021 - 01/2015
4	Wounds and Injuries (Trauma) 01/2020 - 05/2011
4	Pneumonia (Pneumonitis) 01/2020 - 04/2014
4	Rheumatoid Arthritis 05/2019 - 09/2011
4	Stomach Neoplasms (Stomach Cancer) 01/2019 - 01/2009
4	Ischemia 11/2017 - 05/2009

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2008
17	Biomarkers (Surrogate Marker)IBA 02/2024 - 09/2008
16	honokiolIBA 01/2022 - 01/2008
13	Liposomes (Liposome)IBA 01/2020 - 01/2008
12	Therapeutic UsesIBA 01/2023 - 12/2009
12	MicellesIBA 10/2019 - 04/2011
11	Paclitaxel (Taxol)FDA LinkGeneric 11/2022 - 05/2010
10	CytokinesIBA 04/2024 - 05/2010
10	CarrageenanIBA 02/2020 - 04/2011
9	Long Noncoding RNAIBA 12/2023 - 01/2018
9	Phosphotransferases (Kinase)IBA 08/2023 - 01/2017
9	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 08/2008
9	EnzymesIBA 12/2021 - 08/2010
8	Indicators and Reagents (Reagents)IBA 03/2024 - 11/2014
8	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 08/2009
7	Chimeric Antigen ReceptorsIBA 01/2024 - 11/2019
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2012
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2009
7	MicroRNAs (MicroRNA)IBA 02/2021 - 04/2010
7	Interleukin-6 (Interleukin 6)IBA 01/2021 - 05/2010
6	Peptides (Polypeptides)IBA 04/2024 - 07/2010
6	CholesterolIBA 03/2024 - 04/2011
6	LipidsIBA 03/2024 - 01/2012
6	Janus Kinase 2IBA 01/2024 - 11/2019
6	Bortezomib (Velcade)FDA Link 01/2023 - 01/2019
6	TubulinIBA 01/2023 - 04/2014
6	Small Interfering RNA (siRNA)IBA 12/2021 - 01/2009
6	AminesIBA 02/2021 - 01/2015
6	Messenger RNA (mRNA)IBA 01/2014 - 01/2006
5	LigandsIBA 04/2024 - 06/2011
5	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2018
5	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2008
5	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 11/2020
5	Antineoplastic Agents (Antineoplastics)IBA 10/2020 - 10/2014
5	Triglycerides (Triacylglycerol)IBA 11/2014 - 06/2012
4	InterferonsIBA 04/2024 - 01/2013
4	Protein Kinases (Protein Kinase)IBA 02/2024 - 12/2018
4	PolymersIBA 01/2023 - 01/2015
4	Angiotensin IIIBA 08/2022 - 01/2016
4	Proteasome InhibitorsIBA 01/2022 - 11/2019
4	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 06/2014
4	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2016
4	QuercetinIBA 12/2021 - 04/2009
4	AntioxidantsIBA 12/2021 - 09/2011
4	CollagenIBA 01/2021 - 01/2011
4	indium-bleomycinIBA 07/2020 - 01/2011
4	SolutionsIBA 06/2020 - 07/2018
4	FlavonoidsIBA 11/2019 - 04/2009
4	Histone Deacetylase InhibitorsIBA 09/2019 - 04/2008
4	monomethoxypolyethylene glycol (MPEG)IBA 07/2018 - 11/2015
4	millepachineIBA 08/2016 - 08/2012
4	Ethylene Glycol (Monoethylene Glycol)IBA 11/2015 - 12/2009
4	Amino Acids FDA Link 10/2015 - 04/2010
4	Insulin (Novolin)FDA Link 12/2014 - 06/2012
4	5- (4- methoxybenzylidene)thiazolidine- 2,4- dioneIBA 08/2014 - 11/2010
3	CateninsIBA 02/2024 - 03/2017

Therapy/Procedure

62	Therapeutics 04/2024 - 09/2008
24	Oral Administration 01/2023 - 11/2010
18	Drug Therapy (Chemotherapy) 12/2023 - 04/2010
6	Transplantation 12/2021 - 05/2010
4	Immunotherapy 04/2024 - 12/2019
4	Radiotherapy 12/2023 - 04/2010
4	Hematopoietic Stem Cell Transplantation 01/2022 - 04/2014
4	Noninvasive Ventilation 01/2022 - 11/2017